Microglia: an active player in the regulation of synaptic activity

Kyungmin Ji, Jeremy Miyauchi, Stella E Tsirka, Kyungmin Ji, Jeremy Miyauchi, Stella E Tsirka

Abstract

Synaptic plasticity is critical for elaboration and adaptation in the developing and developed brain. It is well established that astrocytes play an important role in the maintenance of what has been dubbed "the tripartite synapse". Increasing evidence shows that a fourth cell type, microglia, is critical to this maintenance as well. Microglia are the resident macrophages of the central nervous system (CNS). Because of their well-characterized inflammatory functions, research has primarily focused on their innate immune properties. The role of microglia in the maintenance of synapses in development and in homeostasis is not as well defined. A number of significant findings have shed light on the critical role of microglia at the synapse. It is becoming increasingly clear that microglia play a seminal role in proper synaptic development and elimination.

Figures

Figure 1
Figure 1
Microglia alter the synaptic density of hippocampal neurons. Hippocampal neurons with or without microglia were stained with PSD95 (green), synapsin I (blue), and phalloidin (red) (a). The smaller boxes show magnified images. Arrows depict PSD95+ synapsin 1− puncta. Scale bars: 20 μm (upper panel); 5 μm (lower panel). Quantification of spine numbers (b), PSD95+synapsin 1+ puncta (c), and PSD95+ synapsin 1+ puncta in total PSD95+ puncta (d) in neurons cultured with or without microglia. Values are presented as mean ± SEM and expressed as a percent of the neurons-only control sample (adapted from [28]).
Figure 2
Figure 2
Microglial tPA deficiency preserves the levels of synaptic adhesion molecules. (a) Hippocampal neurons at 19 DIV were cocultured with microglia for 2 days. (b) The western blot analysis of the levels of N-cadherin, pan-γ-protocadherin, and SynCAM-1 in neurons in the absence or presence of microglia from wild-type (WT) or tPAKO(tPA−/−) mice. α-Tubulin was used as a loading control. (c) Quantification was performed using the ImageJ software and normalized against α-tubulin (n = 4). *P < 0.05 compared to neurons alone.
Figure 3
Figure 3
Schematic depicting some of the potential mechanisms through which microglia can affect neuronal activity. Potential interactions between neurons, astrocytes, and microglia at the synapse. The area depicted by the red circle is magnified in inset. Inset: microglial processes in proximity to neuronal synapses can modify neuronal activity via multiple potential pathways. They can secrete proteases to modulate the stability of synaptic adhesion molecules (which in turn influences synaptic transmission) or remove complement-tagged structures. They can release ectosomes that directly interact with the neuronal membranes and initiate signaling cascades. They can also affect directly glutamatergic or GABAergic transmission.

References

    1. Skaper SD. Ion channels on microglia: therapeutic targets for neuroprotection. CNS & Neurological Disorders Drug Targets. 2011;10(1):44–56.
    1. Kreutzberg GW. Microglia, the first line of defence in brain pathologies. Arzneimittel-Forschung. 1995;45(3):357–360.
    1. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences. 1996;19(8):312–318.
    1. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841–845.
    1. Ginhoux F, Lim S, Hoeffel G, Low D, Huber T. Origin and differentiation of microglia. Frontiers in Cellular Neuroscience. 2013;7, article 45
    1. Kierdorf K, Erny D, Goldmann T, et al. Microglia emerge from erythromyeloid precursors via Pu. 1- and Irf8-dependent pathways. Nature Neuroscience. 2013;16:273–280.
    1. Neumann H, Wekerle H. Brain microglia: watchdogs with pedigree. Nature Neuroscience. 2013;16:253–255.
    1. Eggen BJ, Raj D, Hanisch UK, Boddeke HW. Microglial phenotype and adaptation. Journal of Neuroimmune Pharmacology. 2013;8:807–823.
    1. Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron. 2013;77:10–18.
    1. Altman J. Microglia emerge from the fog. Trends in Neurosciences. 1994;17(2):47–49.
    1. Aloisi F. Immune function of microglia. Glia. 2001;36(2):165–179.
    1. Piani D, Spranger M, Frei K, Schaffner A, Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. European Journal of Immunology. 1992;22(9):2429–2436.
    1. Emmetsberger J, Tsirka SE. Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury. Neurobiology of Disease. 2012;47:295–309.
    1. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. Journal of Immunology. 1992;149(8):2736–2741.
    1. Wu M, Tsirka SE. Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia. 2009;57(11):1204–1215.
    1. Barger SW, Basile AS. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. Journal of Neurochemistry. 2001;76(3):846–854.
    1. Shin WH, Lee D-Y, Park KW, et al. Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia. 2004;46(2):142–152.
    1. Park KW, Lee DY, Joe EH, Kim SU, Jin BK. Neuroprotective role of microglia expressing interleukin-4. Journal of Neuroscience Research. 2005;81(3):397–402.
    1. Colton CA, Wilcock DM. Assessing activation states in microglia. CNS and Neurological Disorders. 2010;9(2):174–191.
    1. Mandrekar-Colucci S, Karlo JC, Landreth GE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. The Journal of Neuroscience. 2012;32:10117–10128.
    1. Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Experimental Neurology. 2012;237:147–152.
    1. Gao Z, Tsirka SE. Animal models of MS reveal multiple roles of microglia in disease pathogenesis. Neurology Research International. 2011;2011:9 pages.383087
    1. Hu X, Li P, Guo Y, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43:3063–3070.
    1. Kumar A, Stoica BA, Sabirzhanov B, Burns MP, Faden AI, Loane DJ. Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiology of Aging. 2013;34:1397–1411.
    1. Mikita J, Dubourdieu-Cassagno N, Deloire MS, et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis: amelioration of clinical status by M2 activated monocyte administration. Multiple Sclerosis. 2011;17(1):2–15.
    1. Wu M, Nissen JC, Chen EI, Tsirka SE. Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis. PLoS ONE. 2012;7(4)e34933
    1. Shechter R, Schwartz M. Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer “if” but ‘how’. The Journal of Pathology. 2013;229:332–346.
    1. Ji K, Akgul G, Wollmuth LP, Tsirka SE. Microglia actively regulate the number of functional synapses. PLoS ONE. 2013;8e56293
    1. Zhuo M, Small SA, Kandel ER, Hawkins RD. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science. 1993;260(5116):1946–1950.
    1. Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNFα . Science. 2002;295(5563):2282–2285.
    1. Nistico R, Mango D, Mandolesi G, et al. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLoS ONE. 2013;8e54666
    1. Ajmone-Cat A, Mancini M, De Simone R, Cilli P, Minghetti L. Microl polarization and plasticity: evidence from organotypic hippocampal slice cultures. Glia. 2013;61:1698–1711.
    1. Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Experimental Neurology. 2002;176(2):336–341.
    1. Min SS, Quan HY, Ma J, Han J-S, Jeon BH, Seol GH. Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area. Neuroscience Letters. 2009;456(1):20–24.
    1. Zhong Y, Zhou L-J, Ren W-J, et al. The direction of synaptic plasticity mediated by C-fibers in spinal dorsal horn is decided by Src-family kinases in microglia: the role of tumor necrosis factor-α . Brain, Behavior, and Immunity. 2010;24(6):874–880.
    1. Roumier A, Pascual O, Béchade C, et al. Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS ONE. 2008;3(7)e2595
    1. Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience. 2005;8(6):752–758.
    1. Nimmerjahn A, Kirchhoff F, Helmchen F. Neuroscience: resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314–1318.
    1. Tremblay M-Ě, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biology. 2010;8(11)e1000527
    1. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. Journal of Neuroscience. 2009;29(13):3974–3980.
    1. Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456–1458.
    1. Sierra A, Abiega O, Shahraz A, Neumann H. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Frontiers in Cellular Neuroscience. 2013;7, article 6
    1. Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691–705.
    1. Tang L, Hung CP, Schuman EM. A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron. 1998;20(6):1165–1175.
    1. Mendez P, De Roo M, Poglia L, Klauser P, Muller D. N-cadherin mediates plasticity-induced long-term spine stabilization. Journal of Cell Biology. 2010;189(3):589–600.
    1. Yamagata K, Andreasson KI, Sugiura H, et al. Arcadlin is a neural activity-regulated cadherin involved in long term potentiation. Journal of Biological Chemistry. 1999;274(27):19473–19479.
    1. Shiosaka S, Yoshida S. Synaptic microenvironments: structural plasticity, adhesion molecules, proteases and their inhibitors. Neuroscience Research. 2000;37(2):85–89.
    1. Kaczmarek L, Lapinska-Dzwonek J, Szymczak S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO Journal. 2002;21:6643–6648.
    1. Dzwonek J, Rylski M, Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Letters. 2004;567(1):129–135.
    1. Qian Z, Gilbert M, Colicos M, Kandel E, Kuhl D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature. 1993;361:453–457.
    1. Gualandris A, Jones T, Strickland S, Tsirka S. Membrane depolarization induces the Ca2+-dependent release of tissue plasminogen activator. Journal of Neuroscience. 1996;16(7):2220–2225.
    1. Huang Y, Bach M, Lipp H, et al. Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proceedings of the National Academy of Sciences of the USA. 1996;93:8699–8704.
    1. Baranes D, Lederfein D, Huang YY, Chen M, Bailey C, Kandel E. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron. 1998;21:813–825.
    1. Madani R, Hulo S, Toni N, et al. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO Journal. 1999;18:3007–3012.
    1. Neuhoff H, Roeper J, Schweizer M. Activity-dependent formation of perforated synapses in cultured hippocampal neurons. European Journal of Neuroscience. 1999;11:4241–4250.
    1. Restituito S, Khatri L, Ninan I, et al. Synaptic autoregulation by metalloproteases and γ-secretase. Journal of Neuroscience. 2011;31(34):12083–12093.
    1. Wang X, Lee S-R, Arai K, et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nature Medicine. 2003;9(10):1313–1317.
    1. Dityatev A, Schachner M. Extracellular matrix molecules and synaptic plasticity. Nature Reviews Neuroscience. 2003;4(6):456–468.
    1. Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biological Chemistry. 2002;383(5):725–737.
    1. Dobrenis K, Chang H-Y, Pina-Benabou MH, et al. Human and mouse microglia express connexin36, and functional gap junctions are formed between rodent microglia and neurons. Journal of Neuroscience Research. 2005;82(3):306–315.
    1. Garg S, Syed MM, Kielian T. Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. Journal of Neurochemistry. 2005;95(2):475–483.
    1. Oviedo-Orta E, Evans WH. Gap junctions and connexin-mediated communication in the immune system. Biochimica et Biophysica Acta. 2004;1662(1-2):102–112.
    1. Mika T, Prochnow N. Functions of connexins and large pore channels on microglial cells: the gates to environment. Brain Research. 2012;1487:16–24.
    1. Maezawa I, Jin L-W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. Journal of Neuroscience. 2010;30(15):5346–5356.
    1. Cronin M, Anderson PN, Cook JE, Green CR, Becker DL. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Molecular and Cellular Neuroscience. 2008;39(2):152–160.
    1. Li Y, Du XF, Liu CS, Wen ZL, Du JL. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Developmental Cell. 2012;23:1189–1202.
    1. Domercq M, Vazquez-Villoldo N, Matute C. Neurotransmitter signaling in the pathophysiology of microglia. Frontiers in Cellular Neuroscience. 2013;7, article 49
    1. Wong WT, Wang M, Li W. Regulation of microglia by ionotropic glutamatergic and GABAergic neurotransmission. Neuron Glia Biology. 2011;7:41–46.
    1. Lee M, Schwab C, Mcgeer PL. Astrocytes are GABAergic cells that modulate microglial activity. Glia. 2011;59(1):152–165.
    1. Fontainhas AM, Wang M, Liang KJ, et al. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS ONE. 2011;6(1)e15973
    1. Mandolesi G, Grasselli G, Musella A, et al. GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 2012;46(2):414–424.
    1. Rossi S, Muzio L, De Chiara V, et al. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 2011;25(5):947–956.
    1. Sadallah S, Eken C, Schifferli JA. Ectosomes as modulators of inflammation and immunity. Clinical and Experimental Immunology. 2011;163(1):26–32.
    1. Antonucci F, Turola E, Riganti L, et al. Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO Journal. 2012;31(5):1231–1240.
    1. Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 2009;8(13):2014–2018.
    1. Bianco F, Perrotta C, Novellino L, et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO Journal. 2009;28(8):1043–1054.
    1. Kwaan HC, Magalhães Rego E. Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Seminars in Thrombosis and Hemostasis. 2010;36(8):917–924.
    1. Siao C-J, Tsirka SE. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. Journal of Neuroscience. 2002;22(9):3352–3358.
    1. Hedhli N, Falcone DJ, Huang B, et al. The annexin A2/S100A10 system in health and disease: emerging paradigms. Journal of Biomedicine and Biotechnology. 2012;2012:13 pages.406273
    1. Gauthier-Kemper A, Weissmann C, Golovyashkina N, et al. The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2-dependent manner. Journal of Cell Biology. 2011;192(4):647–661.
    1. Ning L, Wang C, Ding X, Zhang Y, Wang X, Yue S. Functional interaction of TRPV4 channel protein with annexin A2 in DRG. Neurological Research. 2012;34:685–693.
    1. Warner-Schmidt JL, Schmidt EF, Marshall JJ, et al. Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:11360–11365.
    1. Schafer DP, Lehrman EK, Stevens B. The “quad-partite” synapse: micro-synapse interactions in the developing and mature CNS. Glia. 2013;61:24–36.

Source: PubMed

3
Suscribir